Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

Gee, J M; Robertson, J F; Gutteridge, E; Ellis, I O; Pinder, S E; Rubini, M; Nicholson, R I

Gee, J M; Robertson, J F; Gutteridge, E; Ellis, I O; Pinder, S E; Rubini, M; Nicholson, R I.

Affiliation

Gee JM; Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Redwood Building, Cardiff University, Cardiff, UK. gee@cardiff.ac.uk

Endocr Relat Cancer ; 12 Suppl 1: S99-S111, 2005 Jul.

Article in En | MEDLINE | ID: mdl-16113104

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Breast Neoplasms/drug therapy; Estrogen Antagonists/therapeutic use; Receptor Cross-Talk; Tamoxifen/therapeutic use; Breast Neoplasms/metabolism; Drug Resistance, Neoplasm; ErbB Receptors/metabolism; Estrogens/deficiency; Female; Humans; Phosphorylation; Receptor, ErbB-2/metabolism; Receptors, Estrogen/metabolism; Receptors, Somatomedin/metabolism; Signal Transduction

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Antineoplastic Agents, Hormonal / Receptor Cross-Talk / Estrogen Antagonists Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Endocr Relat Cancer Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2005 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links